scholarly journals A REVIEW OF PATTERN OF HEAD AND NECK MALIGNANCIES SEEN IN SOKOTO, NIGERIA BETWEEN 2005 and 2010

2013 ◽  
Vol 1 (3) ◽  
Author(s):  
Abdullahi M ◽  
Sahabi SM ◽  
Iseh KR ◽  
Amutta SB ◽  
Aliyu D

BACKGROUND Head and neck cancers have a global burden and are more burdensome especially in the developing countries where risk factors, late presentation and low socioeconomic status still predominate. OBJECTIVE To determine any change in the pattern of head and neck cancers in the Usmanu Danfodiyo University Teaching Hospital, Sokoto after 5 years. METHOD This is a retrospective five year study (2005-2010) of 146 histologically diagnosed head and neck cancers from the registers of the department of histopathology. RESULTS One hundred and forty six head and neck cancer patients were studied representing 18.6% of the total number of 787 histologically diagnosed malignancies during the study period (2005-2010). There were 93 males (63.7%) and 53 female (36.3%). The male to female ratio was 1.8:1. The ages of patients ranged from3-89 years with the mean age of 41.6 ± 20.5 years. The highest number of patients was seen in the th 5 decade (21.2%) of life. There were 112(76.7%) carcinomas, 20(13.7%) lymphomas, 5(3.4%) sarcomas and 9(6.2%) blastomas. Seventy cases (47.9%) were head and neck squamous cell carcinoma. Sinonasal carcinoma 24(16.4%) was the commonest Head and neck cancer. Retinoblastoma 5(3.4%) was the commonest childhood head and neck cancer. CONCLUSION There was no significant change in the pattern of the head and neck cancers (P > 0.05). Sinonasal cancinoma was the commonest head and neck malignant tumour. Head and cancers still remains a challenge in this region.

Author(s):  
Ali Ali AL-Zamzami

Objective: The main objective of this study is to study head and neck cancer among Yemenis to establish a reliable database, determine the common histopathological type, common site, and defined the relation of the type and size to the age and gender of patients. Material and Methods: This study design was a prospective descriptive hospital-based study, carried out atAl-Komori–Teaching Hospital in the Sana’aRepublic of Yemen (major referral center of oncology). The material of this study consisted of 633 patients with head and neck cancer referred for management at the department of oral and maxillofacial surgery and to the consultant unit of the head and neck surgery and who were diagnosed clinically, radiographically and histopathology as having head and neck cancer. A patient who presented with recurrent cancer, or who had previous treatment with radiation or chemotherapy were excluded. Datawerecollectedfrompatienthistory (using a questionnaire sheet), clinical examination of patients, radiograph examination and from the histopathology results of the biopsies. Data have entered the computer and analysis using Statistical Package for Social Science (SPSS) (version 24). Quantitative data were summarized using simple descriptive statistics of mean and standard deviation (SD). A Chi-square test was used to assess the association and the level of significance among categorical variables. A P-value of less than 0.05 is considered statistically significant. Results: During the study period, 633 cases of head and neck cancers were seen, 355 cases (55.9%) were males and 279 cases (44.1%) were females, male to female ratio was 1.3:1. The patient age was ranged from 3 to 95 years with a mean age of 59.05 years ±std=15.9 years. The majority of cases (94.9%) were carcinomas, followed by lymphoma 2.5% and sarcoma 1.4%. The less common types were malignant melanoma and malignant fibrous histiocytoma, accounting 0.9 %and 0.2% respectively. Squamous cell carcinoma was the most common type of head and neck carcinoma, accounting (72.9%). Of lymphoma, all cases were Burkitt's lymphoma. Osteosarcoma was the most common type of sarcoma, accounting 55.5% of all sarcoma. The most common affected sites were oral cavity and facial skin, accounting 66.0% and 21.8% respectively. The less affected sites were salivary glands, jawbones and maxillary sinus, accounting 4.4%, 4.1% and 3.6% respectively. Of the oral cavity, the gingiva was the most affected site, followed by the tongue, accounting (33.3%) and (31.0%). Naso-labial region, infra-orbital region were the most common affected sites of the facial skin, accounting (23.9%) and (18.8%) respectively. Basal cell carcinoma and squamous cell carcinoma were the most common types of accounting, 75.4% and 23.2% respectively. Conclusion: The present study demonstrated the distribution of the head and neck cancers among Yemenis, determine the common type, common site and the relationship between the type and site to the age and gender of patients. In Yemen as in all countries, head and neck cancers were remained the disease of elderly male patients with a male to female ratio of 1.3:1. Patient age was running from 3 to 95 years. The majority of patients (90.9 %) were over the age of 40 years. Carcinoma was the commonest type, followed by lymphoma and sarcoma, accounting, 94.9%, 2.5% and 1.4% respectively. The oral cavity (66.0%) was the most affected site, followed by the facial skin accounting 21.8 %. The less affected sites were salivary glands, jawbones and maxillary sinus, accounting 4.4%, 4.1% and 3.6%respectively.


BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Yannan Wang ◽  
Mengxue Wang ◽  
Yan Tang ◽  
Bincan Sun ◽  
Kai Wang ◽  
...  

Abstract Background Head and neck cancers are aggressive cancers, most clinical studies focused on the prognosis of patients with head and neck cancer. However, perioperative mortality was rarely mentioned. Methods A retrospective analysis was performed using all head and neck cancer patients admitting in the Department of Oral and Maxillofacial Surgery of the Second Xiangya Hospital, Central South University from January 2010 to December 2019. The analysis of overall survival and progression-free survival were performed using the Kaplan–Meier method, and cross tabulation with chi-squared testing was applied to analyze the difference in parameters between groups. Results From January 2010 to December 2019, a total of 6576 patients with head and neck cancers were admitted to our department and 7 died in the hospital, all of whom were middle-aged and elderly patients including 6 males and 1 female. The perioperative mortality rate (POMR) was about 1‰. The causes of death included acute heart failure, rupture of large blood vessels in the neck, hypoxic ischemic encephalopathy due to asphyxia, respiratory failure and cardiopulmonary arrest. Conclusion Preoperative radiotherapy, previous chemotherapy, hypertension, diabetes, advanced clinical stage and postoperative infection are risk factors for perioperative mortality of head and neck cancer.


2010 ◽  
Vol 2 (1) ◽  
pp. 43-51
Author(s):  
Vedang Murthy ◽  
Sayan Kundu ◽  
Tanweer Shahid ◽  
Ashwini Budrukkar ◽  
Tejpal Gupta ◽  
...  

Abstract Though early stage head and neck cancers can be cured either by surgery or radiation, patients with locally advanced disease continues to pose a therapeutic challenge. Locoregional failure is the major cause of death in head and neck cancers. As the outcome of locally advanced head and neck cancer is less than promising, a combined modality approach is generally undertaken in this group of patients. The combination of surgery, radiation and more recently, chemotherapy and targeted therapy can improve outcomes in locally advanced head and neck cancer patients. This overview discusses the rationale and role of postoperative radiotherapy (PORT) in advanced head and neck cancers, the radiotherapy technique in brief and methods of enhancing the efficacy of postoperative RT by altering the fractionation schedules and adding chemotherapy and targeted therapy.


OTO Open ◽  
2021 ◽  
Vol 5 (4) ◽  
pp. 2473974X2110594
Author(s):  
Peter Yao ◽  
Victoria Cooley ◽  
William Kuhel ◽  
Andrew Tassler ◽  
Victoria Banuchi ◽  
...  

Objective The coronavirus disease 2019 (COVID-19) pandemic has reduced the demand for, and supply of, head and neck cancer services. This study compares the times to diagnosis, staging, and treatment of head and neck cancers before and during the COVID-19 pandemic. Study Design Retrospective cohort study. Setting Tertiary academic medical center in New York City (NYC). Methods The times to diagnosis, staging, and treatment of head and neck cancer for patients presenting to the clinics of 4 head and neck oncology surgeons with newly diagnosed head and neck cancers were compared between pre–COVID-19 and COVID-19 periods. Results Sixty-eight patients in the pre–COVID-19 period and 26 patients in the COVID-19 period presented with newly diagnosed head and neck cancer. Patients in the COVID-19 group had a significantly longer time to diagnosis than the pre–COVID-19 group after adjustment for age and cancer diagnosis ( P = .02; hazard ratio [HR], 0.54; 95% CI, 0.32-0.92). Patients in the pre–COVID-19 and COVID-19 groups had no statistically significant differences in time to staging ( P > .9; HR, 1.01; 95% CI, 0.58-1.74) or time to treatment ( P = .12; HR, 1.55; 95% CI, 0.89-2.72). Conclusion This study found that time to diagnosis for head and neck cancers was delayed during a COVID-19 period compared to a pre–COVID-19 period. However, there was no evidence of delays in time to staging and time to treatment during the COVID-19 period. Our results prompt further investigations into the factors contributing to diagnostic delays but provide reassurance that despite COVID-19, patients were receiving timely staging and treatment for head and neck cancers.


Author(s):  
Frederic Ivan L. Ting ◽  
Aylmer Rex B. Hernandez ◽  
Reno Eufemon P. Cereno ◽  
Irisyl B. Orolfo-Real ◽  
Corazon A. Ngelangel

<p class="abstract"><strong><span lang="EN-US">Background: </span></strong>In the management of head and neck cancer (HNC), assessment of quality of life (QoL) is imperative because of the potentially debilitating effect of treatment toxicities. Currently, there are no published data assessing the QoL in Filipino HNC patients, thus this study.</p><p class="abstract"><strong><span lang="EN-US">Methods: </span></strong>This cross-sectional study utilized the University of the Philippines - Department of Health Quality of Life scale. Patients with head and neck cancers at the University of the Philippines - Philippine General Hospital from February to September 2019 were invited to participate.  </p><p class="abstract"><strong><span lang="EN-US">Results: </span></strong>A total of 418 patients were included in the study with a mean age of 42 years old (range 18 to 73 years old). In general, Filipino head and neck cancer patients had moderate QoL (mean score of 4.59±0.79). All of the QoL domains (physical, emotional, cognitive, and related functions) had a score of 3-5 (moderate), except for the social status domain which had a mean score of 5.51±0.83 (high). Among socio-demographic factors, patients who are employed and with additional funding sources on top of their income have better global QoL (p&lt;0.01). Clinically, patients with higher stages of disease, fungating tumors, post-laryngectomy, have a feeding tube, with a tracheostomy, and had chemotherapy have lower global QoL (p&lt;0.01).</p><p class="abstract"><strong><span lang="EN-US">Conclusions: </span></strong>Filipino patients with head and neck cancers have an overall moderate quality of life, with high scores in the social domain. Patients with higher tumor burdens and have been exposed to chemotherapy have lower QoL scores, while patients with financial stability and aid have better QoL scores.</p><p class="abstract"><span lang="EN-US"> </span></p>


2010 ◽  
Vol 28 (18) ◽  
pp. 2996-3001 ◽  
Author(s):  
Lester J. Peters ◽  
Brian O'Sullivan ◽  
Jordi Giralt ◽  
Thomas J. Fitzgerald ◽  
Andy Trotti ◽  
...  

Purpose To report the impact of radiotherapy quality on outcome in a large international phase III trial evaluating radiotherapy with concurrent cisplatin plus tirapazamine for advanced head and neck cancer. Patients and Methods The protocol required interventional review of radiotherapy plans by the Quality Assurance Review Center (QARC). All plans and radiotherapy documentation underwent post-treatment review by the Trial Management Committee (TMC) for protocol compliance. Secondary review of noncompliant plans for predicted impact on tumor control was performed. Factors associated with poor protocol compliance were studied, and outcome data were analyzed in relation to protocol compliance and radiotherapy quality. Results At TMC review, 25.4% of the patients had noncompliant plans but none in which QARC-recommended changes had been made. At secondary review, 47% of noncompliant plans (12% overall) had deficiencies with a predicted major adverse impact on tumor control. Major deficiencies were unrelated to tumor subsite or to T or N stage (if N+), but were highly correlated with number of patients enrolled at the treatment center (< five patients, 29.8%; ≥ 20 patients, 5.4%; P < .001). In patients who received at least 60 Gy, those with major deficiencies in their treatment plans (n = 87) had a markedly inferior outcome compared with those whose treatment was initially protocol compliant (n = 502): −2 years overall survival, 50% v 70%; hazard ratio (HR), 1.99; P < .001; and 2 years freedom from locoregional failure, 54% v 78%; HR, 2.37; P < .001, respectively. Conclusion These results demonstrate the critical importance of radiotherapy quality on outcome of chemoradiotherapy in head and neck cancer. Centers treating only a few patients are the major source of quality problems.


2007 ◽  
Vol 89 (2) ◽  
pp. 113-117 ◽  
Author(s):  
SAR Nouraei ◽  
J Philpott ◽  
SM Nouraei ◽  
DCK Maude ◽  
GS Sandhu ◽  
...  

INTRODUCTION Modern delivery of cancer care through patient-centred multidisciplinary teams (MDT) has improved survival. This approach, however, requires effective on-going co-ordination between multiple specialties and resources and can present formidable organisational challenges. The aim of this study was to improve the efficiency of the MDT process for head and neck cancer. PATIENTS AND METHODS A systems analysis of the MDT process was undertaken to identify bottlenecks delaying treatment planning. The MDT process was then audited. A revised process was developed and an Intranet-based data management solution was designed and implemented. The MDT process was re-evaluated to complete the audit cycle. RESULTS We designed and implemented a trust-wide menu-driven database with interfaces for registering and tracking patients, and automated worklists for pathology and radiology. We audited our MDT for 11 and 10 weeks before and following the introduction of the database, with 226 and 187 patients being discussed during each period. The database significantly improved cross-specialtity co-ordination, leading to a highly significant reduction in the number of patients whose treatment planning was delayed due to unavailability of adjunctive investigations (P < 0.001). This improved the overall efficiency of the MDT by 60%. CONCLUSIONS The NHS Cancer Plan aspires to reduce the referral-to-treatment time to 1 month. We have shown that a simple, trust-wide database reduces treatment planning delays in a sizeable proportion of head and neck cancer patients with minimal resource implications. This approach could easily be applied in other MDT meetings.


2012 ◽  
Vol 126 (6) ◽  
pp. 552-555 ◽  
Author(s):  
J Aswani ◽  
K Baidoo ◽  
J Otiti

AbstractHead and neck cancers pose an especially serious problem in developing countries due to late presentation requiring complex surgical intervention. These countries are faced with many challenges, ranging from insufficient health care staff to problems with peri-operative requirements, diagnostic facilities, chemoradiation services and research funding.These challenges can be addressed through the training of head and neck surgeons and support personnel, the improvement of cancer awareness in local communities, and the establishment of dedicated head and neck institutes which focus on the special needs of head and neck cancer patients.All these changes can best be achieved through collaborative efforts with external partners. The Karl Storz Fellowship in Advanced Head and Neck Cancer, enabling training at the University of Cape Town, South Africa, has served as a springboard towards establishing head and neck services in developing sub-Saharan African countries.


2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
K Daga ◽  
L Argus ◽  
J Goswami

Abstract Introduction As of 11th of March 2020, the World Health Organization (WHO) declared the novel coronavirus 2019 (COVID-19) a pandemic. It is estimated that urgent cancer referrals have reduced 70-89% across hospitals in England during the COVID-19 pandemic, in addition to reductions in attendance for the different treatment arms. The aim of our investigation is to assess the impact of COVID-19 on MDT outcomes and patients attending/receiving treatment as compared to before for head and neck cancer. Method Data was collected retrospectively over a period of 203 days (7th January to 28th July 2020), including 66 patients prior to COVID-19 being declared a pandemic and 116 patients since, at a regional cancer centre. A total of 182 patients undergoing treatment were identified. These patients were assessed by TNM staging, MDT outcomes and final initial treatment intents, which were compared to pre-COVID outcomes. Results With respect to MDT outcomes, there was an increase in the number of patients decided for surgery from 10.61% to 23.28% (p = 0.78) during the first wave of the pandemic. Patients decided for radiotherapy and chemotherapy increased by 12.49% and 4.31% respectively. Notably, there was a decrease in further investigations and referrals from 37.88% to 18.10%. Moreover, an increase in palliative treatment intent by 10.55% was noted during the pandemic. Conclusions As the UK enters into the next peak of the pandemic, with reduced capacity for elective surgery and outpatient clinics, it is essential to consider its impact on the standard of care delivered to current cancer patients.


Sign in / Sign up

Export Citation Format

Share Document